©The Author(s) 2020.
World J Clin Oncol. Aug 24, 2020; 11(8): 614-628
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.614
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.614
Table 4 Clinicohistopathological profile of patients with urothelial carcinoma of bladder
| Clinicohistopathological variables | n (%) |
| Total no. of patients | 87 (100) |
| Age (yr) mean, range | 58.3, 25-83 |
| n < 60 | 44 (50.17) |
| n ≥ 60 | 43 (49.42) |
| Gender | |
| Male | 81 (93.10) |
| Female | 8 (9.19) |
| Hematuria | |
| Present | 87(100) |
| Absent | Nil |
| No information | Nil |
| Smoking/Tobacco chewing status | |
| Smokers | 66 (75.86) |
| Non-smokers | 21 (24.1) |
| Tumor grade | |
| Low | 34 (39.04) |
| High | 53 (60.91) |
| Tumor stage | |
| Ta-T1 (Low/NMIBC) | 42 (48.27) |
| T2-T4 (High/MIBC) | 45 (51.72) |
| Tumor type | |
| Primary | 61 (70.11) |
| Recurrent | 26 (29.88) |
| Tumor Size | |
| > 3 cm | 20 (22.98) |
| < 3 cm | 67 (77.01) |
- Citation: Tripathi K, Goel A, Singhai A, Garg M. Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder. World J Clin Oncol 2020; 11(8): 614-628
- URL: https://www.wjgnet.com/2218-4333/full/v11/i8/614.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i8.614